Stock 4147 TAIMED BIOLOGICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar TaiMed Biologics Inc.

Equities

4147

TW0004147004

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-05-29 pm EDT 		5-day change 1st Jan Change
88.6 TWD -0.56% Intraday chart for TaiMed Biologics Inc. +1.72% +8.05%
May. 20 Orient Europharma Co., Ltd. Signs an Exclusive Sales and Marketing Agreement for the New AIDS Drug Trogarzo in Taiwan with Taimed Biologics CI
May. 20 TaiMed Biologics Inc. and Orient EuroPharma Company Limited Signs Trogarzo Commercial License Agreement in Taiwan CI

Chart calendar TaiMed Biologics Inc.

54f6619744f.iggk8Zne0OzPY_wsYj6DRs_ZoId-a-IuMomVpIxy_9Q.43JmxdO7moO1IYZiLQnMHoW16OokIqB8SLvCzb0Dhey6YWXA_Z2ov_hbxA~cbdd45ae9245d0eb14768e8ea704400c

Upcoming events on TaiMed Biologics Inc.

2024-08-08 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-02-20 Q4 2024 Earnings Release (Projected)
2025-05-08 Q1 2025 Earnings Release (Projected)

Past events on TaiMed Biologics Inc.

2024-05-27 09:30 pm Annual General Meeting
2024-05-14 Q1 2024 Earnings Release
2024-05-05 April 2024 Sales and Revenue Release
2024-04-02 03:06 am March 2024 Sales and Revenue Release
2024-03-14 04:27 am Q4 2023 Earnings Release
2024-03-05 February 2024 Sales and Revenue Release
2024-02-05 January 2024 Sales and Revenue Release
2024-01-09 03:06 am December 2023 Sales and Revenue Release
2023-12-07 04:15 am November 2023 Sales and Revenue Release
2023-11-14 12:49 am Q3 2023 Earnings Release
2020-06-03 Annual General Meeting
2019-06-05 09:30 pm Annual General Meeting
2018-06-05 09:30 pm Annual General Meeting
2016-11-02 Q3 2016 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million TWD		Released
Forecast
Spread 		705
757
-6.91%		722
722
0.03%		413
535
-22.72%		563
521
8.01%		492
909
-45.91%
1 424

EBITDA
Million TWD		Released
Forecast
Spread 		-297
-287
-3.66%		7,02
7,98
-12.01%		-330
-136
-143.09%		-35,4
84,3
-141.99%		-10,8
305
-103.56%
1 003

EBIT
Million TWD		Released
Forecast
Spread 		-390
-381
-2.47%		-133
-133
0.09%		-486
-286
-70.07%		-192
-79,2
-142.27%		-166
-29,0
-474.07%
295

Earnings before Tax (EBT)
Million TWD		Released
Forecast
Spread 		-579
-519
-11.46%		-183
-183
-0.17%		-471
-260
-81.13%		-269
-108
-148.7%		-195
-13,7
-1324.54%
320

Net income
Million TWD		Released
Forecast
Spread 		-579
-499
-15.89%		-183
-183
-0.08%		-471
-211
-123.3%		-269
-108
-148.65%		-195
-26,4
-636.79%
242

EPS
TWD		Released
Forecast
Spread 		-2,30
-2,06
-11.72%		-0,73
-0,73
0%		-1,87
-0,84
-123.95%		-1,07
-0,43
-148.84%		-0,77
-0,11
-592.32%
0,96

Announcement Date26/03/2026/03/2131/03/2210/03/2320/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million TWD		Released
Forecast
Spread 		40,7
41,0
-0.8%		99,3
106
-6.33%		96,6
89,0
8.52%		326
300
8.82%		71,8
76,0
-5.57%		104
92,0
13.31%		158
138
14.58%		158
148
7.26%		179
104
72.07%
133


188


197

EBITDA
Million TWD		Released
Forecast
Spread 		-63,1
-77,0
18.04%		-16,4
-44,0
62.65%





-32,0
-301
89.36%		-26,5
-197
86.56%		35,4
46,0
-23.02%		12,2
286
-95.72%		1,71
48,0
-96.45%
76,0


113


111

EBIT
Million TWD		Released
Forecast
Spread 		-102
-153
33.2%		-55,6
-77,0
27.84%		-59,4
-65,0
8.6%		25,3
144
-82.41%		-71,1
-223
68.1%		-65,3
-59,0
-10.68%		-3,29
-40,0
91.78%		-26,5
-32,0
17.19%		-37,1
-49,0
24.39%
-38,5


-17,0


-13,5

Earnings before Tax (EBT)
Million TWD		Released
Forecast
Spread 		-120
-110
-8.88%		-75,8
-76,0
0.31%





-80,8
-371
78.22%		-47,8
-268
82.15%		-5,88
-39,5
85.12%		-60,3
-29,5
-104.36%		-16,0
-43,0
62.7%
-39,0


-17,5


-13,0

Net income
Million TWD		Released
Forecast
Spread 		-120
-164
26.97%		-75,8
-76,0
0.31%		-36,0
-62,0
41.97%		-37,8
150
-125.19%		-80,8
-222
63.52%		-47,8
-50,0
4.32%		-5,88
-39,5
85.12%		-60,3
-29,5
-104.36%		-16,0
-43,0
62.7%
-37,0


-17,5


-15,0

EPS
TWD		Released
Forecast
Spread 		-0,47
-0,65
27.69%		-0,30
-0,30
0%		-0,14
-0,25
44%		-0,15
0,59
-125.42%		-0,32
-0,88
63.64%		-0,19
-0,20
5%		-0,02
-0,16
87.3%		-0,24
-0,12
-104.26%		-0,06
-0,17
64.71%
-0,14


-0,06


-0,05

Announcement Date13/05/2215/08/2211/11/2210/03/2312/05/2311/08/2314/11/2320/03/2414/05/24---

Upcoming sector events for TaiMed Biologics Inc.

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for TaiMed Biologics Inc.

2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 08:00 am IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4147 Stock
  4. Calendar TaiMed Biologics Inc.